Back to search
FDAFDA · Food and drugs·Recall number D-0648-2022

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.

Published February 23, 2022 · Recall initiated: February 11, 2022

Summary

FDA records drug Class I recall D-0648-2022, published February 23, 2022 and initiated February 11, 2022. Recalling firm: Revive Rx LLC dba Revive Rx Pharmacy; Status: Terminated; Reported quantity: 115 vials; Lot: Lot: 631359 BUD: 05/01/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Revive Rx LLC dba Revive Rx Pharmacy
Distributor
Nationwide in the US.
Lot
Lot: 631359 BUD: 05/01/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01. recalled?

Yes. FDA published recall D-0648-2022 on February 23, 2022. Reported hazard: Non-sterility; bacterial contamination identified as Paenibacillus lautus.

What should I do if I have this product?

Voluntary: Firm initiated · Letter